Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
BNKL on OTC
There are no Buy or Sell transactions made by Andre-Jacques Auberton-Herve since 06 Mar 2025
Holdings reported by Andre-Jacques Auberton-Herve for Bionik Laboratories Corp.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,109,271 |
$665,563 |
$0.6000 |
13 Jun 2023 |
Shares held through Star SCI |
|
|
| Common Stock |
95,149 |
$57,089 |
$0.6000 |
13 Jun 2023 |
Direct |
|
|
| Common Stock |
10,693 |
$6,416 |
$0.6000 |
13 Jun 2023 |
Shares held through 4A Consulting and Engineering |
|
|
| Convertible Promissory Note |
1 |
|
|
13 Jun 2023 |
Through Star SCI |
Common Stock, par value $0.001 per share |
|
Transactions reported by Andre-Jacques Auberton-Herve for Bionik Laboratories Corp.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.